In this episode of The Dairy Health Blackbelt Podcast, Tiarna Scerri, PhD candidate at the Gulbali Institute in Australia, explains how antimicrobial resistance is changing mastitis treatment research. She discusses synthetic biology, farmer-centered product design, regulation, and why new therapies must be both effective and practical for dairy farms. Listen now on all major platforms!"Alternative mastitis treatments need to be effective, sustainable, and practical enough for farmers to adopt from the start."Meet the guest: Tiarna Scerri is a PhD candidate at the Gulbali Institute in Australia, developing alternative treatments for mastitis to address antimicrobial resistance in major mastitis-causing bacteria. She holds degrees in science and law, advocates for proactive regulation of agricultural biotechnology, and is part of the 2026 Groundbreakers Program, a cohort whose endeavors are supported by AgriFutures Australia. Learn more from Tiarna Scerri on The Dairy Health Blackbelt Podcast, available on all major platforms.Liked this one? Don’t stop now — Here’s what we think you’ll love!What you will learn:(00:00) Highlight(01:28) Introduction(01:52) Ag law background(04:08) Resistance challenge(06:15) Synthetic biology(07:28) Farm practicality(10:28) Commercial outlook(11:43) Closing thoughtsThe Dairy Health Blackbelt Podcast is trusted and supported by the innovative companies like:* inBarn𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.Website: The Dairy Health Blackbelt PodcastInstagram: The Dairy Health Blackbelt PodcastLinkedIn: The Dairy Health Blackbelt Podcast

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related